Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Shailly Gupta @TBAlliance makes a presentation on its new drug pretomanid that has huge potential to treat XDR #tuberculosis. But the price remains too high. Says @MSF_access msfaccess.org/price-announce… 23:09 - 29 Oct 2019